Table 2.
Height, weight and sex adjusted lung function† at | ||||||
---|---|---|---|---|---|---|
Age 11yr (n=109) | Age 16yr (n=87) | Age 22yr (n=83) | ||||
r‡ | p | r‡ | p | r‡ | p | |
Pre-bronchodilator | ||||||
FEV1/FVC Ratio | 0.38 | <0.001 | 0.32 | 0.003 | 0.34 | 0.002 |
FEF25-75 | 0.34 | <0.001 | 0.33 | 0.002 | 0.30 | 0.006 |
FEV1 | 0.18 | 0.06 | 0.18 | 0.09 | 0.18 | 0.1 |
FVC | -0.03 | 0.7 | -0.03 | 0.8 | -0.07 | 0.5 |
Post-bronchodilator | ||||||
FEV1/FVC Ratio | 0.26 | 0.007 | 0.28 | 0.01 | 0.30 | 0.006 |
FEF25-75 | 0.31 | 0.001 | 0.28 | 0.01 | 0.27 | 0.01 |
FEV1 | 0.09 | 0.4 | 0.14 | 0.2 | 0.13 | 0.2 |
FVC | -0.06 | 0.6 | -0.02 | 0.9 | -0.04 | 0.7 |
V'maxFRC measured in infancy was logarithmically transformed, adjusted for length and standardized to the average length of the infants at 2 months of age (57.4 cm) as previously reported (4)
Spirometry indices were regressed with height, weight and sex and the standardized residuals saved and used as the outcome measure
Pearson correlation coefficient